Current Assets
Income taxes receivable
Eli Lilly Income taxes receivable decreased by 8.5% to $11.80B in Q1 2026 compared to the prior quarter. Over 2 years (FY 2022 to FY 2025), Income taxes receivable shows an upward trend with a 133.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2022
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase may indicate overpayment of estimated taxes or the accrual of refundable credits, representing a potential source of near-term cash inflow.
Detailed definition
This represents the amount of income tax overpayments or refundable tax credits that the company expects to recover from...
Peer comparison
Common for large corporations that manage complex tax filings across multiple jurisdictions.
Metric ID:
income_taxes_receivableHistorical Data
7 periods
| Q4 '22 | Q3 '23 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $2.37B | $4.08B | $7.13B | $16.40B | $18.69B | $12.90B | $11.80B |
| QoQ Change | — | +72.2% | +74.8% | +130.0% | +14.0% | -31.0% | -8.5% |
| YoY Change | — | — | — | — | — | +80.9% | — |
Range$2.37B – $18.69B
CAGR+191.6%
Avg YoY Growth+80.9%
Median YoY Growth+80.9%
Current Streak2 quarters decline
Income taxes receivable at Other Companies
Frequently Asked Questions
- What is Eli Lilly's income taxes receivable?
- Eli Lilly (LLY) reported income taxes receivable of $11.80B in Q1 2026.
- What is the long-term trend for Eli Lilly's income taxes receivable?
- Over 2 years (2022 to 2025), Eli Lilly's income taxes receivable has grown at a 133.3% compound annual growth rate (CAGR), from $2.37B to $12.90B.
- What does income taxes receivable mean?
- Tax refunds or credits owed to the company by government tax agencies.